7 drug(s) with this reaction
1,215 total reports
Injection Site Pain has been reported as an adverse reaction across 7 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,215 adverse event reports mention injection site pain in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with injection site pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have injection site pain listed in their FDA adverse event reports, sorted by report count:
In addition to injection site pain, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
7 drug(s) manufactured by Chattem Inc have injection site pain listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, LIDOCAINE HCL, DOXYLAMINE SUCCINATE, and others.
There are a combined 1,215 reports of injection site pain across 7 Chattem Inc drug(s) in the FDA adverse event database.